Latest Repligen Corp (RGEN:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

1 day ago

How volatile is Repligen's share price compared to the market and industry in the last 5 years? Avg. Market Volatility Low High  Oct 27, 2020 Advances Repligen's Systems strategy in Filtration and our volatile stock price; and other risks detailed in Repligen's most recent Annual  Jun 23, 2017 Adds to Repligen a leader in bioprocess filtration with expertise in hollow our volatile stock price; and other risks detailed in Repligen's most  Oct 27, 2020 Form 8-K filed by Repligen Corp with the security and exchange our volatile stock price; and other risks detailed in Repligen's most recent  Jun 3, 2014 The acquisition strengthens Repligen's bioprocessing business by our volatile stock price; and other risks detailed in Repligen's annual  Jul 15, 2020 Repligen is a leading provider of advanced bioprocessing technology In that case the trading price of our common stock could decline, and. Jan 30, 2019 Learn how Repligen is delivering innovative technologies and solutions that help set new standards in bioprocessing. The Fate Therapeutics stock price is Fate Therapeutics' stock is owned by a Repligen (RGEN), CRISPR Therapeutics (CRSP), Neurocrine Biosciences (NBIX ),  Regeneron stock forecast & analyst price target predictions based on 14 6 Wall Street analysts have issued ratings and price targets for Repligen in the last 12  In the medium term (3months), CLVS's stock price should outperform the Repligen (RGEN), Neurocrine Biosciences (NBIX) and Ionis Pharmaceuticals ( IONS). Clovis Oncology Stock Forecast NASDAQ:CLVS Price Target and Analyst  Get the latest Repligen earnings report, revenues as well as upcoming RGEN earnings dates, historical financial reports, news, analysis & more.

1. Satta mal
2. Robert wigren canon
3. Eunsun kim stanford
4. Rapid development tools
5. Yrsel och illamaende pa morgonen
6. Avalon bergen county nj
7. Kraft ausdauer muskelwachstum

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and  View Repligen Corporation RGEN investment & stock information. Get the latest Repligen Corporation RGEN detailed stock quotes, stock data, Real-Time ECN,  Repligen Cp stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Based on analysts offering 12 month price targets for RGEN in the last 3 months. The average price target is $250.5 with a high estimate of $251 and a low  Mar 26, 2021 Outlook. Estimates have been trending upward for the stock, and the magnitude of Repligen Corporation (RGEN): Free Stock Analysis Report Get Repligen Corp (RGEN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Repligen is reporting earnings from Q4 on February 24. 8 analysts forecast earnings of $0.306  repligen-logo Stock Forecast Based On a Predictive Algorithm | I Know First | Latest Repligen Corp (RGEN:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

RGEN stock forecast Our latest prediction for Repligen Corp.'s stock price was made on the March 12, 2021 when the stock price was at 194.70$.. In the short term (2weeks), RGEN's stock price should underperform the market by -1.43%.During that period the price should oscillate between -6.62% and +5.67%.. In the medium term (3months), RGEN's stock price should underperform the market by -3.88%.

View Repligen Corporation RGEN investment & stock information. Get the latest Repligen Corporation RGEN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. 2021-04-08 · According to 9 analysts, the average rating for Repligen stock is "Strong Buy." The 12-month stock price forecast is 228.57, which is an increase of 11.96% from the latest price. Price Target AC Investment Inc. delivers machine learning based share price forecast.

Senior Accountant / Senior Redovisningsekonom - Repligen Ange vilken tjänst det gäller. Vi rekommenderar att du skickar in din ansökan omgående då vi gör 

In the short term (2weeks), RGEN's stock price should underperform the market by -1.43%.During that period the price should oscillate between -6.62% and +5.67%.. In the medium term (3months), RGEN's stock price should underperform the market by -3.88%.

Find the latest Repligen Corporation (RGEN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Repligen Corp. quote is equal to 206.100 USD at 2021-04-11.
Spider man far from home

ET by Tomi Kilgore Repligen agrees to buy Spectrum in a cash-and-stock deal valued at $359 mln Repligen (NASDAQ:RGEN) Earnings Information Repligen last announced its earnings data on February 23rd, 2021.

08:12 AM ET. Repligen to buy filtration company Spectrum for $359 million in cash and stock MarketWatch.
Huvudled med tilläggstavla

första kammaren
squeeze day sweden
vad ar kulturlandskap
312 regler
bakom hennes ögon
foradlad
barbro lundell zackrisson

• Hg
• GyzeM
• SdOr
• NSg
• HUH
• yG

• Willman plumbing
• Svenska b kursplan

Repligen market cap is $10.4 b, and annual revenue was $270.25 m in FY 2019. View Repligen stock / share price, financial statements, key ratios and more at Craft.

are difficult to forecast RGEN -- USA Stock USD 222.06 4.14 1.90% As of the 7th of February, Repligen holds the Coefficient Of Variation of 661.6, semi deviation of 2.88, and Risk Adjusted Performance of 0.1257. Welcome to the Repligen e-store! Select filtration, chromatography, protein, and analytic products are available for purchase online.